Celldex Therapeutics (CLDX) Q1 2023 Earnings

28FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-0.59
-0.54
-0.5
-0.45

Details

Expected EPS
-0.59
Actual EPS
-0.56
Surprise EPS
0.03
Surprise Percent
+5.08%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.56 per share for Q1 2023.

0 Comments

Share your thoughts